Press Releases - 2024-05-09
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
Press Releases - 2024-05-07
PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
Press Releases - 2024-04-25
PureTech Announces Annual Results for Year Ended December 31, 2023
Press Releases - 2024-04-16
Internal Program - LYT-100
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis